Subscribe free!

Find out why we're the #1 free penny stock alert newsletter


Bio-Matrix Scientific Group Inc. (BMSN) Stock Falls Friday as Traders Pocket Profits

| |

Shares of Bio-Matrix Scientific Group Inc. (PINK: BMSN), a biotechnology company engaged in the development of regenerative medicine therapies and tools to treat lung, heart, circulatory system and other internal organs, fell sharply in Friday’s trading session.

The penny stock of BMSN ended the day 18.27% lower at $0.0085, with volume up from daily average of 8.30 million to 43.95 million. Despite the sharp decline on Friday, BMSN gained more than 226% in the last three trading sessions.

Bio-Matrix Scientific shares rose sharply last week after the company announced that its subsidiary, Regen BioPharma executed an option agreement to license stem cell intellectual property.

Posted by on Monday, June 11th, 2012. Filed under Internet, Technology. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Leave a Reply